Catheter End Period Cash Flow from 2010 to 2025

VTAK Stock   0.42  0.00  0.000002%   
Catheter Precision End Period Cash Flow yearly trend continues to be quite stable with very little volatility. The value of End Period Cash Flow is projected to decrease to about 3 M. From the period between 2010 and 2025, Catheter Precision, End Period Cash Flow regression line of its data series had standard deviation of  15,489,491 and standard deviation of  15,489,491. View All Fundamentals
 
End Period Cash Flow  
First Reported
2017-03-31
Previous Quarter
16 K
Current Value
1.3 M
Quarterly Volatility
14.7 M
 
Covid
Check Catheter Precision financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Catheter Precision's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 M, Interest Expense of 3.7 M or Total Revenue of 377.9 K, as well as many indicators such as Price To Sales Ratio of 42.94, Dividend Yield of 0.0 or PTB Ratio of 0.99. Catheter financial statements analysis is a perfect complement when working with Catheter Precision Valuation or Volatility modules.
  
Check out the analysis of Catheter Precision Correlation against competitors.
For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.

Latest Catheter Precision's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Catheter Precision over the last few years. It is Catheter Precision's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Catheter Precision's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Pretty Stable
   End Period Cash Flow   
       Timeline  

Catheter End Period Cash Flow Regression Statistics

Arithmetic Mean11,200,911
Geometric Mean6,819,753
Coefficient Of Variation138.29
Mean Deviation9,713,056
Median3,921,000
Standard Deviation15,489,491
Sample Variance239.9T
Range61.3M
R-Value0.16
Mean Square Error250.7T
R-Squared0.02
Significance0.56
Slope510,338
Total Sum of Squares3598.9T

Catheter End Period Cash Flow History

2025M
20243.2 M
20233.6 M
202215.9 M
202115 M
202023.9 M
201914.6 M

About Catheter Precision Financial Statements

Catheter Precision investors utilize fundamental indicators, such as End Period Cash Flow, to predict how Catheter Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
End Period Cash Flow3.2 MM

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Catheter Precision is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Catheter Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Catheter Precision Stock. Highlighted below are key reports to facilitate an investment decision about Catheter Precision Stock:
Check out the analysis of Catheter Precision Correlation against competitors.
For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catheter Precision. If investors know Catheter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catheter Precision listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
30.61
Revenue Per Share
0.604
Quarterly Revenue Growth
(0.03)
Return On Assets
(0.22)
Return On Equity
(0.50)
The market value of Catheter Precision is measured differently than its book value, which is the value of Catheter that is recorded on the company's balance sheet. Investors also form their own opinion of Catheter Precision's value that differs from its market value or its book value, called intrinsic value, which is Catheter Precision's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catheter Precision's market value can be influenced by many factors that don't directly affect Catheter Precision's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catheter Precision's value and its price as these two are different measures arrived at by different means. Investors typically determine if Catheter Precision is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catheter Precision's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.